Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the...
PRNEWSWIRE DUBLIN, November 24 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has submitted a MAA to the European Medicines Agency for...


